164 related articles for article (PubMed ID: 17054047)
1. Liver enzyme-mediated oxidation of Echinacea purpurea alkylamides: production of novel metabolites and changes in immunomodulatory activity.
Cech NB; Tutor K; Doty BA; Spelman K; Sasagawa M; Raner GM; Wenner CA
Planta Med; 2006 Dec; 72(15):1372-7. PubMed ID: 17054047
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes.
Matthias A; Gillam EM; Penman KG; Matovic NJ; Bone KM; De Voss JJ; Lehmann RP
Chem Biol Interact; 2005 Jun; 155(1-2):62-70. PubMed ID: 15885678
[TBL] [Abstract][Full Text] [Related]
3. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells.
Sasagawa M; Cech NB; Gray DE; Elmer GW; Wenner CA
Int Immunopharmacol; 2006 Jul; 6(7):1214-21. PubMed ID: 16714226
[TBL] [Abstract][Full Text] [Related]
4. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts.
Chicca A; Raduner S; Pellati F; Strompen T; Altmann KH; Schoop R; Gertsch J
Int Immunopharmacol; 2009 Jul; 9(7-8):850-8. PubMed ID: 19303464
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of the major Echinacea alkylamide N-isobutyldodeca-2E,4E,8Z,10Z-tetraenamide by human recombinant cytochrome P450 enzymes and human liver microsomes.
Toselli F; Matthias A; Bone KM; Gillam EM; Lehmann RP
Phytother Res; 2010 Aug; 24(8):1195-201. PubMed ID: 20135639
[TBL] [Abstract][Full Text] [Related]
7. Effects of herbal products and their constituents on human cytochrome P450(2E1) activity.
Raner GM; Cornelious S; Moulick K; Wang Y; Mortenson A; Cech NB
Food Chem Toxicol; 2007 Dec; 45(12):2359-65. PubMed ID: 17658211
[TBL] [Abstract][Full Text] [Related]
8. Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide.
Gulledge TV; Collette NM; Mackey E; Johnstone SE; Moazami Y; Todd DA; Moeser AJ; Pierce JG; Cech NB; Laster SM
J Ethnopharmacol; 2018 Feb; 212():166-174. PubMed ID: 29042288
[TBL] [Abstract][Full Text] [Related]
9. Echinacea alkylamides modulate induced immune responses in T-cells.
Matthias A; Banbury L; Bone KM; Leach DN; Lehmann RP
Fitoterapia; 2008 Jan; 79(1):53-8. PubMed ID: 17855021
[TBL] [Abstract][Full Text] [Related]
10. Analysis of alkylamides in Echinacea plant materials and dietary supplements by ultrafast liquid chromatography with diode array and mass spectrometric detection.
Mudge E; Lopes-Lutz D; Brown P; Schieber A
J Agric Food Chem; 2011 Aug; 59(15):8086-94. PubMed ID: 21702479
[TBL] [Abstract][Full Text] [Related]
11. Ethanolic Echinacea purpurea Extracts Contain a Mixture of Cytokine-Suppressive and Cytokine-Inducing Compounds, Including Some That Originate from Endophytic Bacteria.
Todd DA; Gulledge TV; Britton ER; Oberhofer M; Leyte-Lugo M; Moody AN; Shymanovich T; Grubbs LF; Juzumaite M; Graf TN; Oberlies NH; Faeth SH; Laster SM; Cech NB
PLoS One; 2015; 10(5):e0124276. PubMed ID: 25933416
[TBL] [Abstract][Full Text] [Related]
12. Effect on prolactin secretion of Echinacea purpurea, hypericum perforatum and Eleutherococcus senticosus.
Di Carlo G; Pacilio M; Capasso R; Di Carlo R
Phytomedicine; 2005 Sep; 12(9):644-7. PubMed ID: 16194051
[TBL] [Abstract][Full Text] [Related]
13. Alkylamides from echinacea modulate induced immune responses in macrophages.
Matthias A; Banbury L; Stevenson LM; Bone KM; Leach DN; Lehmann RP
Immunol Invest; 2007; 36(2):117-30. PubMed ID: 17365014
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4).
Modarai M; Yang M; Suter A; Kortenkamp A; Heinrich M
Planta Med; 2010 Mar; 76(4):378-85. PubMed ID: 19790031
[TBL] [Abstract][Full Text] [Related]
15. Echinacea metabolism and drug interactions: the case for standardization of a complementary medicine.
Toselli F; Matthias A; Gillam EM
Life Sci; 2009 Jul; 85(3-4):97-106. PubMed ID: 19427870
[TBL] [Abstract][Full Text] [Related]
16. Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MS.
Spelman K; Wetschler MH; Cech NB
J Pharm Biomed Anal; 2009 Jul; 49(5):1141-9. PubMed ID: 19321283
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of Echinacea constituents: Caco-2 monolayers and pharmacokinetics of the alkylamides and caffeic acid conjugates.
Matthias A; Penman KG; Matovic NJ; Bone KM; De Voss JJ; Lehmann RP
Molecules; 2005 Oct; 10(10):1242-51. PubMed ID: 18007516
[TBL] [Abstract][Full Text] [Related]
18. Echinacea purpurea-derived alkylamides exhibit potent anti-inflammatory effects and alleviate clinical symptoms of atopic eczema.
Oláh A; Szabó-Papp J; Soeberdt M; Knie U; Dähnhardt-Pfeiffer S; Abels C; Bíró T
J Dermatol Sci; 2017 Oct; 88(1):67-77. PubMed ID: 28610718
[TBL] [Abstract][Full Text] [Related]
19. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats.
Goel V; Chang C; Slama JV; Barton R; Bauer R; Gahler R; Basu TK
Int Immunopharmacol; 2002 Feb; 2(2-3):381-7. PubMed ID: 11811940
[TBL] [Abstract][Full Text] [Related]
20. The role of alkamides as an active principle of echinacea.
Woelkart K; Bauer R
Planta Med; 2007 Jun; 73(7):615-23. PubMed ID: 17538868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
